Damora Therapeutics, Inc.

Damora Therapeutics, Inc. financial statements

Damora Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 209.84M10-K
Cash and equivalentsUSD 257.62M10-Q
Total debtUSD 68KEODHD

Damora Therapeutics, Inc. financials on 6ix · Damora Therapeutics, Inc. on 6ix